415 related articles for article (PubMed ID: 12743137)
1. Combined-modality therapy of locally advanced cervical cancer.
Rose PG
J Clin Oncol; 2003 May; 21(10 Suppl):211s-217s. PubMed ID: 12743137
[TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM
J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678
[TBL] [Abstract][Full Text] [Related]
3. Novel chemotherapy approaches in chemoradiation protocols.
González-Cortijo L; Carballo N; González-Martín A; Corraliza V; Chiva de Agustín L; Lapuente Sastre F; García García JF; Rojo Sebastián A; Hornedo J; Colomer R
Gynecol Oncol; 2008 Sep; 110(3 Suppl 2):S45-8. PubMed ID: 18678399
[TBL] [Abstract][Full Text] [Related]
4. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer.
Rose PG; Bundy BN; Watkins EB; Thigpen JT; Deppe G; Maiman MA; Clarke-Pearson DL; Insalaco S
N Engl J Med; 1999 Apr; 340(15):1144-53. PubMed ID: 10202165
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of a randomized trial comparing concurrent single agent cisplatin, cisplatin-based combination chemotherapy, or hydroxyurea during pelvic irradiation for locally advanced cervical cancer: a Gynecologic Oncology Group Study.
Rose PG; Ali S; Watkins E; Thigpen JT; Deppe G; Clarke-Pearson DL; Insalaco S;
J Clin Oncol; 2007 Jul; 25(19):2804-10. PubMed ID: 17502627
[TBL] [Abstract][Full Text] [Related]
6. Simultaneous radiochemotherapy in cervical cancer: recommendations for chemotherapy.
Dunst J; Haensgen G
Strahlenther Onkol; 2001 Dec; 177(12):635-40. PubMed ID: 11789401
[TBL] [Abstract][Full Text] [Related]
7. Chemoradiotherapy in the treatment of cervical cancer.
Eifel PJ
Semin Radiat Oncol; 2006 Jul; 16(3):177-85. PubMed ID: 16814159
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
Stehman FB; Bundy BN; Kucera PR; Deppe G; Reddy S; O'Connor DM
Gynecol Oncol; 1997 Aug; 66(2):262-7. PubMed ID: 9264574
[TBL] [Abstract][Full Text] [Related]
9. Concurrent chemotherapy and radiation therapy as the standard of care for cervical cancer.
Eifel PJ
Nat Clin Pract Oncol; 2006 May; 3(5):248-55. PubMed ID: 16683003
[TBL] [Abstract][Full Text] [Related]
10. Recent achievements and future developments in advanced and recurrent cervical cancer: trials of the Gynecologic Oncology Group.
Tewari KS; Monk BJ
Semin Oncol; 2009 Apr; 36(2):170-80. PubMed ID: 19332251
[TBL] [Abstract][Full Text] [Related]
11. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer.
Hitt R; López-Pousa A; Martínez-Trufero J; Escrig V; Carles J; Rizo A; Isla D; Vega ME; Martí JL; Lobo F; Pastor P; Valentí V; Belón J; Sánchez MA; Chaib C; Pallarés C; Antón A; Cervantes A; Paz-Ares L; Cortés-Funes H
J Clin Oncol; 2005 Dec; 23(34):8636-45. PubMed ID: 16275937
[TBL] [Abstract][Full Text] [Related]
12. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
13. The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix.
Thigpen T; Vance R; Khansur T; Malamud F
Semin Oncol; 1996 Jun; 23(3 Suppl 6):56-64. PubMed ID: 8677451
[TBL] [Abstract][Full Text] [Related]
14. A feasibility study of topotecan with standard-dose cisplatin and concurrent primary radiation therapy in locally advanced cervical cancer.
Gatcliffe TA; Tewari KS; Shah A; Brewster WR; Burger RA; Kuo JV; Monk BJ
Gynecol Oncol; 2009 Jan; 112(1):85-9. PubMed ID: 18977518
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of concurrent radiotherapy and chemotherapy for locally advanced cervical cancer: 12-Year survival after radiochemotherapy.
Berclaz G; Gerber E; Beer K; Aebi S; Greiner R; Dreher E; Buser K
Int J Oncol; 2002 Jun; 20(6):1313-8. PubMed ID: 12012015
[TBL] [Abstract][Full Text] [Related]
16. Concomitant and neoadjuvant chemotherapy in conjunction with radiotherapy in the management of locally advanced cervical cancer.
Tattersall MH
J Natl Cancer Inst Monogr; 1996; (21):101-3. PubMed ID: 9023837
[TBL] [Abstract][Full Text] [Related]
17. [Clinical evaluation of chemoradiotherapy for advanced cervical cancer].
Kaneyasu Y; Okawa MK; Okawa T
Gan To Kagaku Ryoho; 1997 Nov; 24(14):2084-91. PubMed ID: 9388517
[TBL] [Abstract][Full Text] [Related]
18. Gynecologic malignancies.
Schilder RJ; Scher RM; Young RC
Cancer Chemother Biol Response Modif; 1993; 14():530-56. PubMed ID: 8312118
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of concurrent and adjuvant carboplatin with radiation therapy for locally advanced cervical cancer.
Dubay RA; Rose PG; O'Malley DM; Shalodi AD; Ludin A; Selim MA
Gynecol Oncol; 2004 Jul; 94(1):121-4. PubMed ID: 15262129
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy in the management of cervical carcinoma.
duPont NC; Monk BJ
Clin Adv Hematol Oncol; 2006 Apr; 4(4):279-86. PubMed ID: 16728939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
